Skip to main content
SpringerLink
Log in

Effects of clonidine and IBMX on sulfobromophthalein disposition in rats

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Clonidine, an α2-adrenoceptor agonist, inhibited the biliary excretion, reduced the plasma clearance and increased the hepatic retention of sulfobromophthalein (BSP) in a dose related fashion in rats. The maximal effects of clonidine on BSP disposition occurred about 4 h after pretreatment. The effects of clonidine on biliary excretion and hepatic retention of BSP were retained following laparotomy (with or without bile duct cannulation); however, the effect of clonidine on plasma disappearance profile was not retained following abdominal surgery. Isobutylmethylxanthine (IBMX) affected BSP disposition in a similar fashion as clonidine, in rats without bile duct cannulation only; no effect of IBMX could be observed in bile duct cannulation rats. Yohimbine, an α2-adrenoceptor antagonist, reversed the effects of clonidine, but not of IBMX, on BSP disposition. It thus seems that clonidine and IBMX exert their effects on BSP disposition by different mechanisms and probably at different sites.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hoefke W. (1980): Clonidine. In: Scriabine A. Ed. Pharmacology of Antihypertensive Drugs. New York, Raven Press, pp. 55–78.

    Google Scholar 

  2. Kobinger W. (1978): Central α-adrenergic systems as targets for hypotensive drugs. Rev. Physiol. Biochem. Pharmacol., 81, 39–100.

    Article  PubMed  CAS  Google Scholar 

  3. van Zwieten P.A., Timmermans P.B.M.W.M. (1983): Pharmacology and characterization of central alpha adrenoceptors involved in the effect of centrally acting antihypertensive drugs. Chest, 83 (suppl 2), 340–343.

    PubMed  Google Scholar 

  4. Ben-Zvi Z., Hurwitz A. (1985): Clonidine effects on sulfobromophthalein disposition in mice. J. Pharmacol. Exp. Ther., 235, 393–397.

    PubMed  CAS  Google Scholar 

  5. Ben-Zvi Z., Hurwitz A. (1986): Effects of morphine and clonidine on sulfobromophthalein disposition in mice. J. Pharm. Pharmacol., 38, 481–483.

    PubMed  CAS  Google Scholar 

  6. Ben-Zvi Z., Hurwitz A. (1987): Effects of adrenoceptor agonists and antagonists on sulfobromophthalein disposition in mice. Eur. J. Pharmacol., 137, 191–196.

    Article  PubMed  CAS  Google Scholar 

  7. Ben-Zvi Z., Graham C.E., Hurwitz A. (1987): Tolerance to the effects of clonidine and morphine on sulfobromophthalein in mice. Life Sci., 40, 1617–1623.

    Article  PubMed  CAS  Google Scholar 

  8. Ben-Zvi Z., Hurwitz A. (1988): Clonidine effects on disposition of xenobiotics in rats: inhibited elimination of flow-limited but not extraction-limited agents. Br. J. Pharmacol., 94, 97–102.

    PubMed  CAS  Google Scholar 

  9. Grant S.J., Redmond Jr D.E. (1982): Methylxanthine activation of noradrenergic activity and reversal by clonidine. Eur. J. Pharmacol., 85, 105–109.

    Article  PubMed  CAS  Google Scholar 

  10. Galloway M.P., Roth R.H. (1983): Neuropharmacology of isobutylmethylxanthine: Effect on central noradrenergic systems in vivo. J. Pharmacol. Exp. Ther., 227, 1–8.

    PubMed  CAS  Google Scholar 

  11. Galloway M.P., Roth R.H. (1983): Clonidine prevents methylxanthine stimulation of norepinephrine metabolism in rat brain. J. Neurochem., 40, 246–251.

    Article  PubMed  CAS  Google Scholar 

  12. Steardo L., Sawynok J. (1985): Clonidine reverses methylxanthine-induced potentiation of baclofen antinociception. Pharmacol. Biochem. Behav., 22, 905–907.

    Article  PubMed  CAS  Google Scholar 

  13. Jard S., Cantau B., Jakobs K.H. (1981): Angiotensin II and α-adrenergic agonists inhibit rat liver adenylate cyclase. J. Biol. Chem., 256, 2603–2606.

    PubMed  CAS  Google Scholar 

  14. Rall T.W. (1980): Central nervous system stimulants: The xanthines. In Goodman A.G., Gilman L.S., Gilman A. Eds. The Pharmacological Basis of Therapeutics. 6th edn. New York, MacMillan Publishing, pp. 592–607.

    Google Scholar 

  15. Whelan G., Combes B. (1971): Competition by unconjugated and conjugated sulfobromophthalein sodium (BSP) for transport into bile. Evidence for a single excretion system. J. Lab. Clin. Med., 78, 230–244.

    PubMed  CAS  Google Scholar 

  16. Steel R.G., Torrie J.H. (1980): Principles and Procedures of Statistics, 2nd edn. New York, McGraw-Hill.

    Google Scholar 

  17. Ozawa H., Chen C.S., Watanabe H., Vematsu T. (1977): Effect of clonidine on blood pressure, heart rate and body temperature in conscious rats. Jpn. J. Pharmacol., 27, 47–54.

    Article  PubMed  CAS  Google Scholar 

  18. Hurwitz A., Fischer H.R., Innis J.D., Ronsse S., Ben-Zvi Z. (1985): Opioid effects on hepatic disposition of dyes in mice. J. Pharmacol. Exp. Ther., 232, 617–623.

    PubMed  CAS  Google Scholar 

  19. Crema A., Benzi G., Berk F. (1962): The action of some natural substances on the terminal portion of the common bile duct isolated ‘in toto’. Arch. Int. Pharmacodyn. Ther., 137, 307–317.

    PubMed  CAS  Google Scholar 

  20. Liedberg G., Persson C.G.A. (1970): Adrenoceptors in cat choledochoduodenal junction studied in situ. Br. J. Pharmacol., 39, 609–626.

    Google Scholar 

  21. Hurwitz A., Fischer H.R. (1983): Narcotic effects on hepatic disposition of sulfobromophthalein in rats. J. Pharmacol. Exp. Ther., 227, 68–72.

    PubMed  CAS  Google Scholar 

  22. Harper M.H., Collins P., Johnson B.H., Eger E.I., Biava C.G. (1982): Postanesthetic hepatic injury in rats: Influence of alterations in hepatic blood flow, surgery and anesthesia time. Anest. Analg., 61, 79–82.

    CAS  Google Scholar 

  23. Gelman S.Y. (1979): Disturbances in hepatic blood flow during anesthesia and surgery. Arch. Surg., 111, 881–883.

    Google Scholar 

  24. Hoffman B.B., Dukes D.F., Lefkowitz R.J. (1980): Alpha adrenergic receptors in liver membranes: Delineation with subtype selective radioligands. Life Sci., 28, 265–272.

    Article  Google Scholar 

  25. Steer M.L., Wood A. (1979): Regulation of human platelet adenylate cyclase by epineppinephrine, prostaglandin E, and guanine nucleotides: Evidence for separate guanine nucleotide sites mediating stimulation and inhibition. J. Biol. Chem., 254, 10791–10797.

    PubMed  CAS  Google Scholar 

  26. Aktories K., Schultz G., Jakobs K.H. (1980): Regulation of adenylate cyclase activity in hamster adipocytes: Inhibition by prostaglandins, α-adrenergic agonists and nicotic acid. Naunyn Schmiedeberg’s Arch. Pharmacol., 312, 167–173.

    Article  CAS  Google Scholar 

  27. Jakobs K.H. (1979): Inhibition of adenylate cyclase by hormones and neurotransmitters. Mol. Cell. Cardiol., 16, 147–156.

    CAS  Google Scholar 

  28. Levine R.A. (1979): The role of cyclic AMP in hepatic and gastrointestinal functions. Gastroenterology, 59, 280–300.

    Google Scholar 

  29. Anden N.E., Grabowska M., Strombom U. (1976): Different alpha-adrenoceptors in the central nervous system mediating biochemical andfunctional effects of clonidine and receptor blocking agents. Naunyn Schmiedeberg’s Arch. Pharmacol., 292, 43–52.

    Article  CAS  Google Scholar 

  30. Paalzow G., Paalzow L. (1976): Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn Schmiedeberg’s Arch. Pharmacol., 292, 119–126.

    Article  CAS  Google Scholar 

  31. Rall T.W. (1982): Evolution of the mechanism of action of methylxanthines: From calcium mobilizers to antagonists of adenosine receptors. Pharmacology, 24, 277–287.

    Google Scholar 

  32. Daly J.W., Jacobson K.A., Ukena D. (1987): Adenosine receptors: Development of selective agonists and antagonists. Prog. Clin. Biol. Res., 230, 41–63.

    PubMed  CAS  Google Scholar 

  33. Williams M. (1987): Purine receptors in mammalian tissues: Pharmacology and functional significance. Annu. Rev. Pharmacol. Toxicol., 27, 315–345.

    Article  PubMed  CAS  Google Scholar 

  34. Williams M., Jarvis M.F. (1988): Adenosine antagonists as potential therapeutic agents. Pharmacol. Biochem. Behav., 29, 433–4

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Corob Center for Medical Sciences, Faculty of Health Sciences, Ben-Gurion University of the Negev, PO Box 653, 84105, Beer-Sheva, Israel

    R. Agbaria & Z. Ben-Zvi

  2. Division of Clinical Pharmacology, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA

    A. Hurwitz

Authors
  1. R. Agbaria
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Hurwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Z. Ben-Zvi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Agbaria, R., Hurwitz, A. & Ben-Zvi, Z. Effects of clonidine and IBMX on sulfobromophthalein disposition in rats. Eur. J. Drug Metab. Pharmacokinet. 18, 239–245 (1993). https://doi.org/10.1007/BF03188802

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03188802

Keywords

Search

Navigation